Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy

被引：0
|
作者：
Dutra-Clarke, Marina [1 ]
Tapia, Daisy [2 ]
Curtin, Emily [2 ]
Ruenger, Dennis [1 ]
Lakatos, Anita [2 ]
Alandy-Dy, Zyza [2 ]
Freedkin, Linda [2 ]
Hall, Kathy [2 ]
Ercelen, Nesrin [2 ]
Alandy-Dy, Jousef [2 ]
Knight, Margaret [2 ]
Pahl, Madeline [2 ]
Lombardo, Dawn [2 ]
Kimonis, Virginia [2 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2020.12.069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
63
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Variable clinical features of patients with Fabry disease and outcome of enzyme replacement therapy
    Dutra-Clarke, Marina
    Tapia, Daisy
    Curtin, Emily
    Runger, Dennis
    Lee, Grace K.
    Lakatos, Anita
    Alandy-Dy, Zyza
    Freedkin, Linda
    Hall, Kathy
    Ercelen, Nesrin
    Alandy-Dy, Jousef
    Knight, Margaret
    Pahl, Madeleine
    Lombardo, Dawn
    Kimonis, Virginia
    [J]. MOLECULAR GENETICS AND METABOLISM REPORTS, 2021, 26
  • [2] Effect of enzyme replacement therapy on clinical outcome in patients with Fabry disease
    Breunig, FB
    Knoll, A
    Weidemann, F
    Strotmann, J
    Wanner, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V246 - V247
  • [3] Clinical features after enzyme replacement therapy in hemodialysis patients with Fabry disease
    Tanaka, M.
    Itoh, K.
    Matsushita, K.
    Matsushita, K.
    Yasumoto, N.
    Ohashi, T.
    Kobayashi, M.
    Eto, Y.
    Nonoguchi, H.
    Tomita, K.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 133 - 133
  • [4] Clinical features and enzyme replacement therapy in 10 children with Fabry disease
    Li, Qian
    Wang, Jing
    Tian, Minle
    Yang, Zhenle
    Yu, Lichun
    Liu, Suwen
    Wang, Cong
    Wang, Xiaoyuan
    Sun, Shuzhen
    [J]. FRONTIERS IN PEDIATRICS, 2023, 11
  • [5] Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
    Hollak, C. E. M.
    Linthorst, G. E.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2009, 96 (01) : 1 - 3
  • [6] Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
    Goicoechea, Marian
    Gomez-Preciado, Francisco
    Benito, Silvia
    Torras, Joan
    Torra, Roser
    Huerta, Ana
    Restrepo, Alejandra
    Ugalde, Jessica
    Estefania Astudillo, Daniela
    Agraz, Irene
    Lopez-Mendoza, Manuel
    de Arriba, Gabriel
    Corchete, Elena
    Quiroga, Borja
    Jose Gutierrez, Maria
    Luisa Martin-Conde, Maria
    Lopes, Vanessa
    Ramos, Carmela
    Mendez, Irene
    Cao, Mercedes
    Dominguez, Fernando
    Ortiz, Alberto
    [J]. NEFROLOGIA, 2021, 41 (06): : 652 - 660
  • [7] Clinical benefit of enzyme replacement therapy in Fabry disease
    Breunig, F
    Weidemann, F
    Strotmann, J
    Knoll, A
    Wanner, C
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (07) : 1216 - 1221
  • [8] Enzyme replacement therapy in Fabry disease: clinical implications
    Breunig, F
    Knoll, A
    Wanner, C
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (05): : 491 - 495
  • [9] Variable clinical features in patients with Fabry disease
    Tapia, Daisy
    Hall, Kathy
    Alandy-Dy, Jousef
    Knight, Margaret
    Lombardo, Dawn
    Pahl, Madeleine
    Kimonis, Virginia
    [J]. MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S129 - S130
  • [10] ENZYME REPLACEMENT THERAPY IMPROVES CARDIAC FEATURES OF FABRY DISEASE
    Motwani, M.
    Banypersad, S.
    Woolfson, P.
    Waldek, S.
    [J]. HEART, 2012, 98 : A40 - A40
12345